Cargando…
Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study
INTRODUCTION: Core disease activity indicators of rheumatoid arthritis (RA) have been found to be limited in predicting joint destruction progression. Matrix metalloproteinase (MMP) 3 plays an essential role in joint destruction and was found elevated in some remission patients. We aimed to monitor...
Autores principales: | Ma, Jian-Da, Wei, Xiu-Ning, Zheng, Dong-Hui, Mo, Ying-Qian, Chen, Le-Feng, Zhang, Xiang, Li, Jing-Hua, Dai, Lie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606896/ https://www.ncbi.nlm.nih.gov/pubmed/26467222 http://dx.doi.org/10.1186/s13075-015-0803-2 |
Ejemplares similares
-
Erratum to: Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study
por: Ma, Jian-Da, et al.
Publicado: (2015) -
Serum Matrix Metalloproteinase-3 as a Noninvasive Biomarker of Histological Synovitis for Diagnosis of Rheumatoid Arthritis
por: Ma, Jian-Da, et al.
Publicado: (2014) -
Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
por: Ally, Mahmood M. T. M., et al.
Publicado: (2013) -
Evaluation of the immune feature of ACPA-negative rheumatoid arthritis and the clinical value of matrix metalloproteinase-3
por: Liang, Zhaojun, et al.
Publicado: (2022) -
Serum matrix metalloproteinase-3 levels monitor the therapeutic efficacy in Syrian patients with rheumatoid arthritis
por: Hussein, Rama, et al.
Publicado: (2023)